Skip to main content
. 2020 Nov 19;12(11):3545. doi: 10.3390/nu12113545

Table 1.

Clinical and biological characteristic of the study population.

Male Healthy Volunteers (n = 71)
Variables Median Q1 Q3 Mini Maxi
Age, year
≥45 years, n (%)
24.0 22.0 36.0 18.0 56.0
13 (18.3)
BMI, kg/m²
>30 kg/m², n (%)
22.7 21.2 24.5 17.2 30.7
2 (2.8)
Waist circumference (cm)
≥102 cm, n (%)
81.0 78.0 87.0 68.0 111.0
3 (4.2)
Systolic blood pressure, mmHg
≥130 mmHg, n (%)
118.0 114.0 126.0 101.0 143.0
11 (15.5)
Diastolic blood pressure, mmHg
≥85 mmHg, n (%)
75.0 71.0 80.0 59.0 98.0
15 (21.1)
Fasting blood glucose, mmol/L
≥5.6 mmol/L, n (%)
4.60 4.40 5.00 3.30 6.10
2 (2.8)
Hba1c, %
5.7% to 6.4%, n (%)
5.30 5.10 5.50 4.40 6.30
9 (12.7)
Insulin, mU/L 3.44 1.41 6.24 0.28 11.3
HOMA-IR 0.69 0.27 1.19 0.05 2.40
Creatinine, µmol/L 88.0 80.0 96.0 72.0 108.0
Creatinine Clearance, mL/min 112.2 95.4 127.8 73.2 171.1
ASAT, UI/L 25.0 22.0 29.0 16.0 37.0
ALAT, UI/L 20.0 16.0 31.0 11.0 54.0
TSH, mUI/L 1.58 1.20 2.12 0.58 3.67
CRPus, mg/L 0.50 0.11 1.39 0.01 6.76
Fasting Lipid phenotyping
Total cholesterol, g/L
>2.5 g/L, n (%)
1.73 1.43 1.95 1.01 2.68
1 (1.4)
LDL-Cholesterol, g/L
>1.6 g/L, n (%)
1.03 0.81 1.20 0.49 1.71
2 (2.8)
HDL-Cholesterol, g/L
≤0.40 g/L, n (%)
0.48 0.41 0.56 0.21 0.77
14 (19.7)
Triglycerides, g/L
>1.5 g/L, n (%)
0.63 0.44 0.85 0.30 2.34
2 (2.8)
Postprandial Triglycerides, g/L
Before test meal, T0: 11:30 a.m. 0.77 0.62 1.10 0.39 4.31
2 h after test meal, T2: 1:30 p.m. 1.46 1.15 1.98 0.53 4.60
4 h after test meal, T4: 3:30 p.m. 1.33 0.96 2.11 5.60 5.67
6 h after test meal, T6: 5:30 p.m. 1.01 0.70 1.56 0.41 5.21
8 h after test meal, T8: 7:30 p.m. 0.71 0.56 0.93 0.32 3.97

BMI: body mass index; ASAT: aspartate aminotransferase; ALAT: alanine aminotransferase; TSH: thyroid-stimulating hormone; LDL: low density lipoprotein; HDL: high density lipoprotein.